Eviti®

Clinical Policies.

Clinical policy guidance on radiation therapy, oncology drug regimens, and oncology imaging, based on NCCN® and FDA standards and reviewed at least annually.

The policy documents open only after the AMA and NCCN terms on this page are accepted. Review the terms

About these policies

NCCN® standards
Primarily based on National Comprehensive Cancer Network® oncology standards.
FDA standards
Aligned with U.S. Food and Drug Administration standards.
Reviewed at least annually
Updated in a timely manner as NCCN and FDA guidance changes, and reviewed annually at a minimum.

NantIQ® provides clinical policy guidelines on radiation oncology treatments and oncology drug regimens. These drug regimens contain chemotherapeutic agents as well as supportive drugs utilized in conjunction with chemotherapy. These policies are primarily based on the National Comprehensive Cancer Network® (NCCN) oncology standards as well as the U.S. Food and Drug Administration (FDA) standards. NCCN consensus clinical standards are periodically updated, and NantIQ® reviews these and updates its policies within a timely manner. They are, at a minimum, reviewed annually if there are no periodic updates during the year from the NCCN or the U.S. FDA. Providers and members can view these oncology policies and guidelines for informational purposes as well as standards regarding dosages and treatment.

Codes and dosing tables

Procedure codes appearing in medical policy documents are only included as a general reference. The list may not be all-inclusive and is subject to updates. In addition, codes listed are not a guarantee of payment. The dosing tables in the policies represent evidence-based doses for the designated type of cancer drug or treatment. Variations outside of the ranges may indicate a deviation from standard treatments.

Attestation required

Accept the terms to view the policies.

Please review and accept the agreements below to view the NantIQ® Clinical Policies, which may include codes and licensed information. The policy documents open once the terms are accepted, and your acceptance is kept for this browser session only.

  1. 1 Accept the terms
  2. View the policies

AMA Disclaimer

CPT codes, descriptions, and other data are copyrighted by the American Medical Association (AMA). All rights are reserved for the date of publication of CPT. CPT is a trademark of the AMA.

Any use not authorized herein is prohibited. A license to use CPT for any use not authorized must be obtained through the AMA.

NCCN Disclaimer

All information provided by the National Comprehensive Cancer Network (NCCN) is “Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) © 2024 and 2025 National Comprehensive Cancer Network. The NCCN Guidelines™ and illustrations herein may not be reproduced in any form for any purpose without the express written permission from the NCCN. To view the most recent and complete version of the NCCN Guidelines, please go online to NCCN.org.”

Available after acceptance

140 policy documents open once the terms are accepted.

  • Radiation Therapy27 policies
  • Medical Oncology85 policies
  • Oncology Imaging28 policies

140 policies

Radiation Therapy

27 policies

Medical Oncology

85 policies

Oncology Imaging

28 policies